Guessing this is Share Prophets14 Feb 2024 17:53
The 2022 AGM was adjourned and then put off and put off. In May 2023 rebel shareholders got a resolution through to reconvene it as soon as possible. Here we are now in February 2024 and the wretched thing still has not been called. Today we are told: Further to the announcement of 27 November 2023, the Company intends to reconvene the 2022 AGM as soon as practicable and a further announcement by the Company in relation to the notice of the 2022 AGM will be made shortly. So Mr Godot promises to come “shortly” – not even tomorrow! This is a laughable state of affairs – and the 2023 AGM is also outstanding, not to mention this year’s in due course. Why have shareholders not been given the opportunity to, amongst other things, quiz the Board over what exactly is going on? They might wonder about the various funding rounds that never materialised. They might wonder about the corporate governance fiasco. They might even wonder why, having been promised an FDR application at IPO by Christmas in 2020 (which was not achieved), the FDA has still not approved the company’s spinal product. But above all, shareholders will surely wonder why the company has limited working capital resources at present and continues to carefully manage its weak cash position and hasn’t managed to repay a loan from apparently sacked director, the saintly Annabel Schild, which was due for repayment by 31st January. Indeed, one might ask why it has taken two weeks for the company to ‘fess up on that. Moreover, it now discloses that it has gone begging bowl in hand to former non-exec Chairman Martin Armstrong for a £50,000 loan, convertible if the company ever gets FDA approval, at 2.5p. This, in addition to the outstanding £30,000 loan from Ms Schild which was used to pay fines imposed by Aquis. The whole thing stinks: the company is surviving, clearly technically insolvent, by a thread. One has to wonder how an Auditor would view its solvency and whether the shares should at least be suspended pending clarification. But there’s no sign of that. Not yet, at any rate. In my view, the whole setup should be kicked off the London markets – anyone invested really is asking for it. The stance remains sell.